Insulin‐degrading enzyme inhibition increases the unfolded protein response and favours lipid accumulation in the liver
British Journal of Pharmacology · 2024
DOI: 10.1111/bph.16436 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2024. Verfasst von Marine Andres und 13 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - EGID Drugs and Molecules for Living Systems, Lille, France. Hauptthemen laut MEDLINE: Endoplasmic Reticulum Stress, Insulysin, Lipid Metabolism, Liver. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Université de Lille, Institut National de la Santé et de la Recherche Médicale, Institute Pasteur De Lille.
Abstract (Originalsprache)
Background and Purpose Nonalcoholic fatty liver disease refers to liver pathologies, ranging from steatosis to steatohepatitis, with fibrosis ultimately leading to cirrhosis and hepatocellular carcinoma. Although several mechanisms have been suggested, including insulin resistance, oxidative stress, and inflammation, its pathophysiology remains imperfectly understood. Over the last decade, a dysfunctional unfolded protein response (UPR) triggered by endoplasmic reticulum (ER) stress emerged as one of the multiple driving factors. In parallel, growing evidence suggests that insulin‐degrading enzyme (IDE), a highly conserved and ubiquitously expressed metallo‐endopeptidase originally discovered for its role in insulin decay, may regulate ER stress and UPR. Experimental Approach We investigated, by genetic and pharmacological approaches, in vitro and in vivo, whether IDE modulates ER stress‐induced UPR and lipid accumulation in the liver. Key Results We found that IDE‐deficient mice display higher hepatic triglyceride content along with higher inositol‐requiring enzyme 1 (IRE1) pathway activation. Upon induction of ER stress by tunicamycin or palmitate in vitro or in vivo, pharmacological inhibition of IDE, using its inhibitor BDM44768, mainly exacerbated ER stress‐induced IRE1 activation and promoted lipid accumulation in hepatocytes, effects that were abolished by the IRE1 inhibitors 4μ8c and KIRA6. Finally, we identified that IDE knockout promotes lipolysis in adipose tissue and increases hepatic CD36 expression, which may contribute to steatosis. Conclusion and Implications These results unravel a novel role for IDE in the regulation of ER stress and development of hepatic steatosis. These findings pave the way to innovative strategies modulating IDE to treat metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - EGID Drugs and Molecules for Living Systems, Lille, France.
- Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
- Université Paris Cité, INSERM, CNRS, Institut Necker Enfants Malades, Paris, France.
- Univ. Lille, UMR-S 1172-JPArc Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, Lille, France.
- Service immunologie biologique, AP-HP, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
- Institut Universitaire de France (IUF), Paris, France.
ORCID-Profile: Steve Lancel
Förderung
- Université de Lille
- Institut National de la Santé et de la Recherche Médicale
- Institute Pasteur De Lille
- Fondation pour la Recherche Médicale
- Centre hospitalier régional universitaire de Lille
- Région Hauts-de-France
- Métropole Européenne de Lille
- European Genomic Institute for Diabetes
Zitieren
APA
Andres, M., Hennuyer, N., Zibar, K., Bicharel-Leconte, M., Duplan, I., Enée, E., Vallez, E., Herledan, A., Loyens, A., Staels, B., Deprez, B., van Endert, P., Deprez-Poulain, R., & Lancel, S. (2024). Insulin‐degrading enzyme inhibition increases the unfolded protein response and favours lipid accumulation in the liver. British Journal of Pharmacology. https://doi.org/10.1111/bph.16436
Vancouver
Andres M, Hennuyer N, Zibar K, Bicharel-Leconte M, Duplan I, Enée E, et al. Insulin‐degrading enzyme inhibition increases the unfolded protein response and favours lipid accumulation in the liver. British Journal of Pharmacology. 2024. doi:10.1111/bph.16436
BibTeX
@article{Andres2024,
author = {Andres, Marine and Hennuyer, Nathalie and Zibar, Khamis and Bicharel-Leconte, Marie and Duplan, Isabelle and Enée, Emmanuelle and Vallez, Emmanuelle and Herledan, Adrien and Loyens, Anne and Staels, Bart and Deprez, Benoit and van Endert, Peter and Deprez-Poulain, Rebecca and Lancel, Steve},
title = {Insulin‐degrading enzyme inhibition increases the unfolded protein response and favours lipid accumulation in the liver},
journal = {British Journal of Pharmacology},
year = {2024},
doi = {10.1111/bph.16436}
}
EUVIMED